Marlene Amstad is Professor of Practice in Economics at the Chinese University of Hong Kong, Shenzhen and Co-Director of the Center for Financial Technology and Social Finance at the Shenzhen Finance Institute. She regularly holds research fellowships with central banks. Most recently, Federal Reserve Bank of New York, the Bank of Japan and the Bank for International Settlements. She serves as the Vice Chair of the Board of Directors of the Swiss Financial Market Supervisory Authority (FINMA).
Douglas W. Arner is the Kerry Holdings Professor in Law at the University of Hong Kong and Project Coordinator of a major five-year project funded by the Hong Kong Research Grants Council Theme-based Research Scheme on “Enhancing Hong Kong’s Future as a Leading International Financial Centre”. In addition, he is Director of the HKU LLM in Compliance and Regulation, and a Senior Visiting Fellow of Melbourne Law School, University of Melbourne.
Jeffrey R. Bohn
Dr. Bohn is the Head of the Swiss Re Research Institute. Most recently, he served as Chief Science Officer and Head of GX Labs at State Street Global Exchange in San Francisco. Before moving back to California, he established the Portfolio Analytics and Valuation Department within State Street Global Markets Japan in Tokyo. He previously ran the Risk and Regulatory Financial Services consulting practice at PWC Japan.
Alexander Braun is Adjunct Professor of Risk Management at the University of St. Gallen. He is a member of the Executive Board of the Institute of Insurance Economics (I.VW-HSG). Before joining the Institute of Insurance Economics, he worked in the Capital Markets Division of Lehman Brothers in London.
Markus K. Brunnermeier is the Edwards S. Sanford Professor at Princeton University and Director of Princeton's Bendheim Center for Finance. He is also a research associate at NBER, CEPR, and CESifo and a member of the Bellagio Group on the International Economy. He is a Sloan Research Fellow, Fellow of the Econometric Society, Guggenheim Fellow and the recipient of the Bernácer Prize granted for outstanding contributions in the fields of macroeconomics and finance.
Jörg Gasser is the State Secretary from the State Secretariat for International Finance from the Swiss Federal Department of Finance. Before he was the division head at the International Committee of the Red Cross (ICRC) headquarters in Geneva, Director of the Federal Office for Migration and Secretary General of the Federal Department of Justice and Police (FDJP).
Kay Giesecke is Professor of Management Science & Engineering at Stanford University. He is the Director of the Advanced Financial Technologies Laboratory and the Director of the Mathematical and Computational Finance Program. Kay is a member of the Institute for Computational and Mathematical Engineering. He serves on the Governing Board and Scientific Advisory Board of the Consortium for Data Analytics in Risk.
Dr. Karpischek is one of the co-founders of Etherisc, a blockchain startup building decentralized insurance applications. Before Etherisc, he co-founded disrupt consulting, a cooperative for digital strategy consulting, educated major banks and telecom enterprises on blockchain technology, and was part of the UBS Crypto Innovation Lab.
Torsten Oletzky is Professor of Strategy and Process Management in the Insurance Industry at TH Köln and a co-founder of InsurLab Germany, an innovation center and co-working space for the insurance industry in Cologne. From 2000 to 2015 he held various management positions for the ERGO Insurance Group and since 2008 he acted as the CEO of the Group.
Michel Rauchs is the Lead in Cryptocurrency and Blockchain at the Cambridge Centre for Alternative Finance (CCAF), an academic research centre at Judge Business School, University of Cambridge. His research explores the cryptocurrency and blockchain landscape, covering the entire spectrum from public blockchains and their cryptoassets to enterprise distributed ledgers.
Kelvin Young is Head of Life and Health Partnerships at Swiss Re. He is responsible for developing partnership relationships and creating impactful and innovative technology and population health management solutions that can be embedded in client propositions. He has worked for Swiss Re for 12 years, which included roles in the UK, New York, Beijing and Hong Kong. He was previously Head of Asia Medical Business for Swiss Re based out of Hong Kong and Global Medical Director based out of the US.